For the Inventor, By the Inventor

Enter assignee name

Sun Pharmaceutical Industries Limited

USPTO Granted Patents = 149

CIPO Patents = 5

EPO Patents = 39

Trademarks = 140

Forward Citations = 261

Loading Chart...

Loading Chart...

251 inventors (with patents filed for the assignee):

Rajamannar Thennati (34 out of 43 patents)

Subhas Balaram Bhowmick (32 out of 42 patents)

Prashant Kane (29 out of 34 patents)

4. Samarth Kumar (25 out of 26 patents)

5. Romi Barat Singh (23 out of 26 patents)

6. Mohan Prasad (13 out of 43 patents)

7. Maheshkumar Parasmal Soni (9 out of 9 patents)

8. Sudeep Kumar Agrawal (8 out of 9 patents)

9. Kirti Ganorkar (8 out of 9 patents)

10. Satish Kumar Jain (8 out of 9 patents)

11. Muthukumaran Natarajan (7 out of 8 patents)

12. Trinadha Rao Chitturi (7 out of 18 patents)

13. Vinod Kumar Arora (7 out of 10 patents)

14. Shavej Ahmad (7 out of 7 patents)

15. Kalaiselvan Ramaraju (7 out of 7 patents)

Core Competencies:

Deuterated D-Serine

GLP-1 Analogues

Intravenous Infusion

Hair Loss Treatment

JAK Inhibitors

Photodynamic Therapy

Topical Formulations

Extended Release Compositions

Non-Steroidal Anti-Inflammatory

Parenteral Dosage Forms

Crystalline Drug Forms

Multi-Particulate Pharmaceuticals

149 patents: Sort by Forward Citations

1. 12508269 - Parenteral dosage form of carboplatin (2025-12-30),

2. 12473252 - Processes for the preparation of deuterated D-serine (2025-11-18),

3. 12421289 - GLP-1 analogues (2025-09-23),

4. 12403070 - Intravenous infusion dosage form (2025-09-02),

5. 12364699 - Method of treating hair loss disorders (2025-07-22),

6. 12350475 - Method of injecting octreotide acetate into the body (2025-07-08),

7. 12325707 - Process for preparing enantiomerically enriched JAK inhibitors (2025-06-10),

8. 12296011 - Methods for photodynamic therapy (2025-05-13),

9. 12290700 - Adjustable illuminator for photodynamic therapy and diagnosis (2025-05-06),

10. 12285432 - Treatment of hair loss disorders with deuterated JAK inhibitors (2025-04-29),

11. 12247034 - Crystalline form of deuruxolitinib phosphate (2025-03-11),

12. 12178812 - Dosage form of vinca alkaloid drug (2024-12-31),

13. 12171742 - Duloxetine sprinkles (2024-12-24),

14. 12161761 - Extended release multiparticulates of ranolazine (2024-12-10),

15. 12156855 - Infusion dosage form of norepinephrine (2024-12-03),

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. It manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) globally. The company's offerings cover various therapeutic areas including dermatology, cardiology, neurology, gastroenterology, and more. Sun Pharma is committed to delivering high-quality, affordable medicines to improve patient's lives worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

149 Patents

#5 in Mumbai

#13 in India

#5,344 in the World

Sun Pharmaceutical Industries Limited

Forward Citations = 261

251 inventors:

Rajamannar Thennati (34 out of 43 patents)

Subhas Balaram Bhowmick (32 out of 42 patents)

Prashant Kane (29 out of 34 patents)

4. Samarth Kumar (25 out of 26 patents)

5. Romi Barat Singh (23 out of 26 patents)

Please report any incorrect information to support@idiyas.com

Loading…